▶ 調査レポート

世界のトランスサイレチンアミロイドーシス（ATTR）市場：市場規模・現状・予測
• 英文タイトル：Global Transthyretin Amyloidosis (ATTR) Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界のトランスサイレチンアミロイドーシス（ATTR）市場：市場規模・現状・予測 / Global Transthyretin Amyloidosis (ATTR) Market Size, Status and Forecast 2019-2025 / QYR9N8143資料のイメージです。• レポートコード：QYR9N8143
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、94ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥585,000 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,170,000 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当資料は、トランスサイレチンアミロイドーシス（ATTR）のグローバル市場について調査・分析したレポートで、種類別（遺伝性ATTR（HATTR）、野生型（WT）ATTR）、用途別（病院、外来手術センター、診断センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・トランスサイレチンアミロイドーシス（ATTR）の世界市場規模
・主要企業別市場シェア
・トランスサイレチンアミロイドーシス（ATTR）の世界市場規模：種類別（遺伝性ATTR（HATTR）、野生型（WT）ATTR）
・トランスサイレチンアミロイドーシス（ATTR）の世界市場規模：用途別（病院、外来手術センター、診断センター）
・トランスサイレチンアミロイドーシス（ATTR）のアメリカ市場規模（種類別、用途別）
・トランスサイレチンアミロイドーシス（ATTR）のヨーロッパ市場規模（種類別、用途別）
・トランスサイレチンアミロイドーシス（ATTR）の中国市場規模（種類別、用途別）
・トランスサイレチンアミロイドーシス（ATTR）の日本市場規模（種類別、用途別）
・トランスサイレチンアミロイドーシス（ATTR）の東南アジア市場規模（種類別、用途別）
・トランスサイレチンアミロイドーシス（ATTR）のインド市場規模（種類別、用途別）
・トランスサイレチンアミロイドーシス（ATTR）の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・トランスサイレチンアミロイドーシス（ATTR）の世界市場予測（2019年-2025年）
・トランスサイレチンアミロイドーシス（ATTR）の地域別市場予測（2019年-2025年）
...

Transthyretin Amyloidosis (ATTR) is an autosomal dominant hereditary disease that occurs due to deposition of variant TTR (transthyretin) protein in humans. It is mainly characterized into two main types i.e. Hereditary ATTR (hATTR) and Wild-Type (wt) ATTR. While Hereditary ATTR is caused by point mutations within TTR allele, wild-type ATTR is caused by the misfolding of Wild-Type TTR. Major prevalence of Hereditary ATTR is observed in the 7MM, and this type has been further sub-classified into Familial Amyloidosis Polyneuropathy (FAP) and Familial Amyloidosis Cardiomyopathy (FAC).United States accounts for highest ATTR Amyloidosis Cases, followed by EU5 (Italy, France, Spain, Germany, UK) and Japan.
In 2018, the global Transthyretin Amyloidosis (ATTR) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Transthyretin Amyloidosis (ATTR) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Transthyretin Amyloidosis (ATTR) development in United States, Europe and China.

The key players covered in this study
Pfizer
Alnylam Pharmaceuticals
Ionis Pharmaceuticals
Corino Therapeutics
Proclara Bioscience 
Arcturus Therapeutics
…

Market segment by Type, the product can be split into
Hereditary ATTR (HATTR)
Wild-Type (WT) ATTR

Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Transthyretin Amyloidosis (ATTR) status, future forecast, growth opportunity, key market and key players.
To present the Transthyretin Amyloidosis (ATTR) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Transthyretin Amyloidosis (ATTR) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Transthyretin Amyloidosis (ATTR) Market Size Growth Rate by Type (2014-2025)
1.4.2 Hereditary ATTR (HATTR)
1.4.3 Wild-Type (WT) ATTR
1.5 Market by Application
1.5.1 Global Transthyretin Amyloidosis (ATTR) Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Diagnostic Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Transthyretin Amyloidosis (ATTR) Market Size
2.2 Transthyretin Amyloidosis (ATTR) Growth Trends by Regions
2.2.1 Transthyretin Amyloidosis (ATTR) Market Size by Regions (2014-2025)
2.2.2 Transthyretin Amyloidosis (ATTR) Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Transthyretin Amyloidosis (ATTR) Market Size by Manufacturers
3.1.1 Global Transthyretin Amyloidosis (ATTR) Revenue by Manufacturers (2014-2019)
3.1.2 Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Transthyretin Amyloidosis (ATTR) Market Concentration Ratio (CR5 and HHI)
3.2 Transthyretin Amyloidosis (ATTR) Key Players Head office and Area Served
3.3 Key Players Transthyretin Amyloidosis (ATTR) Product/Solution/Service
3.4 Date of Enter into Transthyretin Amyloidosis (ATTR) Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Transthyretin Amyloidosis (ATTR) Market Size by Type (2014-2019)
4.2 Global Transthyretin Amyloidosis (ATTR) Market Size by Application (2014-2019)

5 United States
5.1 United States Transthyretin Amyloidosis (ATTR) Market Size (2014-2019)
5.2 Transthyretin Amyloidosis (ATTR) Key Players in United States
5.3 United States Transthyretin Amyloidosis (ATTR) Market Size by Type
5.4 United States Transthyretin Amyloidosis (ATTR) Market Size by Application

6 Europe
6.1 Europe Transthyretin Amyloidosis (ATTR) Market Size (2014-2019)
6.2 Transthyretin Amyloidosis (ATTR) Key Players in Europe
6.3 Europe Transthyretin Amyloidosis (ATTR) Market Size by Type
6.4 Europe Transthyretin Amyloidosis (ATTR) Market Size by Application

7 China
7.1 China Transthyretin Amyloidosis (ATTR) Market Size (2014-2019)
7.2 Transthyretin Amyloidosis (ATTR) Key Players in China
7.3 China Transthyretin Amyloidosis (ATTR) Market Size by Type
7.4 China Transthyretin Amyloidosis (ATTR) Market Size by Application

8 Japan
8.1 Japan Transthyretin Amyloidosis (ATTR) Market Size (2014-2019)
8.2 Transthyretin Amyloidosis (ATTR) Key Players in Japan
8.3 Japan Transthyretin Amyloidosis (ATTR) Market Size by Type
8.4 Japan Transthyretin Amyloidosis (ATTR) Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Transthyretin Amyloidosis (ATTR) Market Size (2014-2019)
9.2 Transthyretin Amyloidosis (ATTR) Key Players in Southeast Asia
9.3 Southeast Asia Transthyretin Amyloidosis (ATTR) Market Size by Type
9.4 Southeast Asia Transthyretin Amyloidosis (ATTR) Market Size by Application

10 India
10.1 India Transthyretin Amyloidosis (ATTR) Market Size (2014-2019)
10.2 Transthyretin Amyloidosis (ATTR) Key Players in India
10.3 India Transthyretin Amyloidosis (ATTR) Market Size by Type
10.4 India Transthyretin Amyloidosis (ATTR) Market Size by Application

11 Central & South America
11.1 Central & South America Transthyretin Amyloidosis (ATTR) Market Size (2014-2019)
11.2 Transthyretin Amyloidosis (ATTR) Key Players in Central & South America
11.3 Central & South America Transthyretin Amyloidosis (ATTR) Market Size by Type
11.4 Central & South America Transthyretin Amyloidosis (ATTR) Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Transthyretin Amyloidosis (ATTR) Introduction
12.1.4 Pfizer Revenue in Transthyretin Amyloidosis (ATTR) Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Alnylam Pharmaceuticals
12.2.1 Alnylam Pharmaceuticals Company Details
12.2.2 Company Description and Business Overview
12.2.3 Transthyretin Amyloidosis (ATTR) Introduction
12.2.4 Alnylam Pharmaceuticals Revenue in Transthyretin Amyloidosis (ATTR) Business (2014-2019)
12.2.5 Alnylam Pharmaceuticals Recent Development
12.3 Ionis Pharmaceuticals
12.3.1 Ionis Pharmaceuticals Company Details
12.3.2 Company Description and Business Overview
12.3.3 Transthyretin Amyloidosis (ATTR) Introduction
12.3.4 Ionis Pharmaceuticals Revenue in Transthyretin Amyloidosis (ATTR) Business (2014-2019)
12.3.5 Ionis Pharmaceuticals Recent Development
12.4 Corino Therapeutics
12.4.1 Corino Therapeutics Company Details
12.4.2 Company Description and Business Overview
12.4.3 Transthyretin Amyloidosis (ATTR) Introduction
12.4.4 Corino Therapeutics Revenue in Transthyretin Amyloidosis (ATTR) Business (2014-2019)
12.4.5 Corino Therapeutics Recent Development
12.5 Proclara Bioscience 
12.5.1 Proclara Bioscience  Company Details
12.5.2 Company Description and Business Overview
12.5.3 Transthyretin Amyloidosis (ATTR) Introduction
12.5.4 Proclara Bioscience  Revenue in Transthyretin Amyloidosis (ATTR) Business (2014-2019)
12.5.5 Proclara Bioscience  Recent Development
12.6 Arcturus Therapeutics
12.6.1 Arcturus Therapeutics Company Details
12.6.2 Company Description and Business Overview
12.6.3 Transthyretin Amyloidosis (ATTR) Introduction
12.6.4 Arcturus Therapeutics Revenue in Transthyretin Amyloidosis (ATTR) Business (2014-2019)
12.6.5 Arcturus Therapeutics Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Transthyretin Amyloidosis (ATTR) Key Market Segments
Table Key Players Transthyretin Amyloidosis (ATTR) Covered
Table Global Transthyretin Amyloidosis (ATTR) Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Transthyretin Amyloidosis (ATTR) Market Size Market Share by Type 2014-2025
Figure Hereditary ATTR (HATTR) Figures
Table Key Players of Hereditary ATTR (HATTR)
Figure Wild-Type (WT) ATTR Figures
Table Key Players of Wild-Type (WT) ATTR
Table Global Transthyretin Amyloidosis (ATTR) Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Diagnostic Centers Case Studies
Figure Transthyretin Amyloidosis (ATTR) Report Years Considered
Table Global Transthyretin Amyloidosis (ATTR) Market Size 2014-2025 (Million US$)
Figure Global Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Transthyretin Amyloidosis (ATTR) Market Size by Regions 2014-2025 (Million US$)
Table Global Transthyretin Amyloidosis (ATTR) Market Size by Regions 2014-2019 (Million US$)
Table Global Transthyretin Amyloidosis (ATTR) Market Share by Regions 2014-2019
Figure Global Transthyretin Amyloidosis (ATTR) Market Share by Regions 2014-2019
Figure Global Transthyretin Amyloidosis (ATTR) Market Share by Regions 2019
Table Market Top Trends
Table Global Transthyretin Amyloidosis (ATTR) Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Transthyretin Amyloidosis (ATTR) Market Share by Manufacturers (2014-2019)
Figure Global Transthyretin Amyloidosis (ATTR) Market Share by Manufacturers in 2018
Table Global Transthyretin Amyloidosis (ATTR) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Transthyretin Amyloidosis (ATTR) Product/Solution/Service
Table Date of Enter into Transthyretin Amyloidosis (ATTR) Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Transthyretin Amyloidosis (ATTR) Market Size by Type (2014-2019) (Million US$)
Table Global Transthyretin Amyloidosis (ATTR) Market Size Share by Type (2014-2019)
Figure Global Transthyretin Amyloidosis (ATTR) Market Size Market Share by Type (2014-2019)
Table Global Transthyretin Amyloidosis (ATTR) Market Size by Application (2014-2019) (Million US$)
Table Global Transthyretin Amyloidosis (ATTR) Market Size Share by Application (2014-2019)
Figure Global Transthyretin Amyloidosis (ATTR) Market Size Market Share by Application (2014-2019)
Figure Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Application in 2018
Figure United States Transthyretin Amyloidosis (ATTR) Market Size 2014-2019 (Million US$)
Table United States Key Players Transthyretin Amyloidosis (ATTR) Revenue (2018-2019) (Million US$)
Table United States Key Players Transthyretin Amyloidosis (ATTR) Market Share (2018-2019)
Table United States Transthyretin Amyloidosis (ATTR) Market Size by Type (2014-2019) (Million US$)
Table United States Transthyretin Amyloidosis (ATTR) Market Share by Type (2014-2019)
Table United States Transthyretin Amyloidosis (ATTR) Market Size by Application (2014-2019) (Million US$)
Table United States Transthyretin Amyloidosis (ATTR) Market Share by Application (2014-2019)
Figure Europe Transthyretin Amyloidosis (ATTR) Market Size 2014-2019 (Million US$)
Table Europe Key Players Transthyretin Amyloidosis (ATTR) Revenue (2018-2019) (Million US$)
Table Europe Key Players Transthyretin Amyloidosis (ATTR) Market Share (2018-2019)
Table Europe Transthyretin Amyloidosis (ATTR) Market Size by Type (2014-2019) (Million US$)
Table Europe Transthyretin Amyloidosis (ATTR) Market Share by Type (2014-2019)
Table Europe Transthyretin Amyloidosis (ATTR) Market Size by Application (2014-2019) (Million US$)
Table Europe Transthyretin Amyloidosis (ATTR) Market Share by Application (2014-2019)
Figure China Transthyretin Amyloidosis (ATTR) Market Size 2014-2019 (Million US$)
Table China Key Players Transthyretin Amyloidosis (ATTR) Revenue (2018-2019) (Million US$)
Table China Key Players Transthyretin Amyloidosis (ATTR) Market Share (2018-2019)
Table China Transthyretin Amyloidosis (ATTR) Market Size by Type (2014-20189) (Million US$)
Table China Transthyretin Amyloidosis (ATTR) Market Share by Type (2014-2019)
Table China Transthyretin Amyloidosis (ATTR) Market Size by Application (2014-2019) (Million US$)
Table China Transthyretin Amyloidosis (ATTR) Market Share by Application (2014-2019)
Figure Japan Transthyretin Amyloidosis (ATTR) Market Size 2014-2019 (Million US$)
Table Japan Key Players Transthyretin Amyloidosis (ATTR) Revenue (2018-2019) (Million US$)
Table Japan Key Players Transthyretin Amyloidosis (ATTR) Market Share (2018-2019)
Table Japan Transthyretin Amyloidosis (ATTR) Market Size by Type (2014-2019) (Million US$)
Table Japan Transthyretin Amyloidosis (ATTR) Market Share by Type (2014-2019)
Table Japan Transthyretin Amyloidosis (ATTR) Market Size by Application (2014-2019) (Million US$)
Table Japan Transthyretin Amyloidosis (ATTR) Market Share by Application (2014-2019)
Figure Southeast Asia Transthyretin Amyloidosis (ATTR) Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Transthyretin Amyloidosis (ATTR) Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Transthyretin Amyloidosis (ATTR) Market Share (2018-2019)
Table Southeast Asia Transthyretin Amyloidosis (ATTR) Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Transthyretin Amyloidosis (ATTR) Market Share by Type (2014-2019)
Table Southeast Asia Transthyretin Amyloidosis (ATTR) Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Transthyretin Amyloidosis (ATTR) Market Share by Application (2014-2019)
Figure India Transthyretin Amyloidosis (ATTR) Market Size 2014-2019 (Million US$)
Table India Key Players Transthyretin Amyloidosis (ATTR) Revenue (2018-2019) (Million US$)
Table India Key Players Transthyretin Amyloidosis (ATTR) Market Share (2018-2019)
Table India Transthyretin Amyloidosis (ATTR) Market Size by Type (2014-2019) (Million US$)
Table India Transthyretin Amyloidosis (ATTR) Market Share by Type (2014-2019)
Table India Transthyretin Amyloidosis (ATTR) Market Size by Application (2014-2019) (Million US$)
Table India Transthyretin Amyloidosis (ATTR) Market Share by Application (2014-2019)
Figure Central & South America Transthyretin Amyloidosis (ATTR) Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Transthyretin Amyloidosis (ATTR) Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Transthyretin Amyloidosis (ATTR) Market Share (2018-2019)
Table Central & South America Transthyretin Amyloidosis (ATTR) Market Size by Type (2014-2019) (Million US$)
Table Central & South America Transthyretin Amyloidosis (ATTR) Market Share by Type (2014-2019)
Table Central & South America Transthyretin Amyloidosis (ATTR) Market Size by Application (2014-2019) (Million US$)
Table Central & South America Transthyretin Amyloidosis (ATTR) Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Transthyretin Amyloidosis (ATTR) Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Transthyretin Amyloidosis (ATTR) Business (2014-2019)
Table Pfizer Recent Development
Table Alnylam Pharmaceuticals Company Details
Table Alnylam Pharmaceuticals Revenue in Transthyretin Amyloidosis (ATTR) Business (2014-2019)(Million US$)
Figure Alnylam Pharmaceuticals Revenue Growth Rate in Transthyretin Amyloidosis (ATTR) Business (2014-2019)
Table Alnylam Pharmaceuticals Recent Development
Table Ionis Pharmaceuticals Company Details
Table Ionis Pharmaceuticals Revenue in Transthyretin Amyloidosis (ATTR) Business (2014-2019)(Million US$)
Figure Ionis Pharmaceuticals Revenue Growth Rate in Transthyretin Amyloidosis (ATTR) Business (2014-2019)
Table Ionis Pharmaceuticals Recent Development
Table Corino Therapeutics Company Details
Table Corino Therapeutics Revenue in Transthyretin Amyloidosis (ATTR) Business (2014-2019)(Million US$)
Figure Corino Therapeutics Revenue Growth Rate in Transthyretin Amyloidosis (ATTR) Business (2014-2019)
Table Corino Therapeutics Recent Development
Table Proclara Bioscience  Company Details
Table Proclara Bioscience  Revenue in Transthyretin Amyloidosis (ATTR) Business (2014-2019)(Million US$)
Figure Proclara Bioscience  Revenue Growth Rate in Transthyretin Amyloidosis (ATTR) Business (2014-2019)
Table Proclara Bioscience  Recent Development
Table Arcturus Therapeutics Company Details
Table Arcturus Therapeutics Revenue in Transthyretin Amyloidosis (ATTR) Business (2014-2019)(Million US$)
Figure Arcturus Therapeutics Revenue Growth Rate in Transthyretin Amyloidosis (ATTR) Business (2014-2019)
Table Arcturus Therapeutics Recent Development
Table Global Transthyretin Amyloidosis (ATTR) Market Size by Regions (Million US$) 2019-2025
Figure Global Transthyretin Amyloidosis (ATTR) Market Size Share by Regions (2019-2025)
Figure Global Transthyretin Amyloidosis (ATTR) Market Size Share by Regions in 2025
Figure United States Transthyretin Amyloidosis (ATTR) Market Size Forecast (2019-2025)(Million USD)
Figure Europe Transthyretin Amyloidosis (ATTR) Market Size Forecast (2019-2025)(Million USD)
Figure China Transthyretin Amyloidosis (ATTR) Market Size Forecast (2019-2025)(Million USD)
Figure Japan Transthyretin Amyloidosis (ATTR) Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Transthyretin Amyloidosis (ATTR) Market Size Forecast (2019-2025)(Million USD)
Figure India Transthyretin Amyloidosis (ATTR) Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Transthyretin Amyloidosis (ATTR) Market Size Forecast (2019-2025)(Million USD)
Table Global Transthyretin Amyloidosis (ATTR) Market Size by Product (2019-2025) (Million US$)
Figure Global Transthyretin Amyloidosis (ATTR) Market Size by Product (2019-2025)
Figure Global Transthyretin Amyloidosis (ATTR) Market Size by Product in 2025
Table Global Transthyretin Amyloidosis (ATTR) Market Size by Application (2019-2025) (Million US$)
Figure Global Transthyretin Amyloidosis (ATTR) Market Size by Application (2019-2025)
Figure Global Transthyretin Amyloidosis (ATTR) Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界のトランスサイレチン市場2019
    Global Transthyretin Sales Market Report 2019
    QYR9N5188 2019年6月14日 109Pages
    本調査レポートでは、トランスサイレチンの世界市場について調査・分析し、トランスサイレチンのメーカー別販売量、市場シェア分析、種類別販売分析（AG-10、ALN-TTRsc02、CRX-1008、EDE-1307、イノテルセンナトリウム、その他）、用途別販売分析（家族性アミロイド神経障害、アルツハイマ...
  • 世界のロミプロスチム市場：市場規模・現状・予測
    Global Romiplostim Market Size, Status and Forecast 2019-2025
    QYR9N7982 2019年6月14日 92Pages
    当資料は、ロミプロスチムのグローバル市場について調査・分析したレポートで、種類別（250 μg/0.5 mL
    、500 μg/1 mL
    ）、用途別（大人、小児患者）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報な...
  • 世界の光原子時計市場：市場規模・現状・予測
    Global Optical Atomic Clocks Market Size, Status and Forecast 2019-2025
    QYR9N7711 2019年6月14日 92Pages
    当資料は、光原子時計のグローバル市場について調査・分析したレポートで、種類別（タイプI、タイプII）、用途別（地上アプリケーション、宇宙アプリケーション）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
    ...
  • 世界の5Gワイヤレステクノロジ市場：市場規模・現状・予測
    Global 5G Wireless Technology Market Size, Status and Forecast 2019-2025
    QYR9N8229 2019年6月14日 97Pages
    当資料は、5Gワイヤレステクノロジのグローバル市場について調査・分析したレポートで、種類別（タイプI、タイプII）、用途別（自動車、携帯電話、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界のエクセナチド市場：市場規模・現状・予測
    Global Exenatide Market Size, Status and Forecast 2019-2025
    QYR9N7180 2019年6月14日 94Pages
    当資料は、エクセナチドのグローバル市場について調査・分析したレポートで、種類別（持続放出注射懸濁液、速放注射懸濁液）、用途別（病院、ドラッグストア）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界のラパチニブ市場：市場規模・現状・予測
    Global Lapatinib Market Size, Status and Forecast 2019-2025
    QYR9N7436 2019年6月14日 98Pages
    当資料は、ラパチニブのグローバル市場について調査・分析したレポートで、種類別（250 mg錠、タイプII）、用途別（病院、ドラッグストア）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・...
  • 世界のA2Pメッセージング市場：市場規模・現状・予測
    Global A2P Messaging Market Size, Status and Forecast 2019-2025
    QYR9N8232 2019年6月14日 92Pages
    当資料は、A2Pメッセージングのグローバル市場について調査・分析したレポートで、種類別（グレイルートA2P SMS、OTT A2Pメッセージング、その他）、用途別（銀行業、発券業務、健康管理、コンテンツ支払い、オペレータの関与、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、イン...
  • 世界のプレリキサフォル市場：市場規模・現状・予測
    Global Plerixafor Market Size, Status and Forecast 2019-2025
    QYR9N7839 2019年6月14日 93Pages
    当資料は、プレリキサフォルのグローバル市場について調査・分析したレポートで、種類別（24MG / 1.2ML、タイプII）、用途別（非ホジキンリンパ腫（NHL）患者、多発性骨髄腫（MM）患者）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情...
  • 世界のラニビズマブ市場：市場規模・現状・予測
    Global Ranibizumab Market Size, Status and Forecast 2019-2025
    QYR9N7929 2019年6月14日 92Pages
    当資料は、ラニビズマブのグローバル市場について調査・分析したレポートで、種類別（使い捨てプレフィルドシリンジ、使い捨てガラスバイアル）、用途別（wAMD、糖尿病性網膜症（DR）、糖尿病性黄斑浮腫（DME）、mCNV、RVO）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）...
  • 世界のシムリン（プラムリンチド）市場：市場規模・現状・予測
    Global Symlin (pramlintide) Market Size, Status and Forecast 2019-2025
    QYR9N8095 2019年6月14日 91Pages
    当資料は、シムリン（プラムリンチド）のグローバル市場について調査・分析したレポートで、種類別（1.5mlペン型注射器、2.7mlペン型注射器）、用途別（I型糖尿病、II型糖尿病）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれ...